Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma-Reference-Cited by-同舟云学术

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma

Published:2014 Issue:2 Volume:3 Page:90-93
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Catania Gioacchino^ORCID,Zallio Francesco,Monaco Federico,Corsetti Maria Teresa,Trincheri Nicol,Bonello Lisa,Mele Lia,Dallavalle Franco,Salvi Flavia,Pini Massimo

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference22 articles.

1. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990;Weidmann;Leukemia,2000

2. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients;Belhadj;Blood,2003

3. Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant;Chalmers;Clin Adv Hematol Oncol,2013

4. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience;Voss;Clin Lymphoma Myeloma Leuk,2013

5. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect;Dodero;Leukemia,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature;Frontiers in Oncology;2024-01-29

2. A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation;Journal of Clinical and Experimental Hematopathology;2020